Menopause is the physiological transition of women to the definitive cessation of ovarian function, with a sustained drop in estrogen and progesterone; it typically occurs between ages 45 and 55 (mean age 51 in Spain); it is preceded by perimenopause (years c… Read more.
15 factors with evidence, ordered from most to least effective. Information, not medical advice.
⏱ 3 min read
Menopause is a woman's physiological transition to the definitive cessation of ovarian function, with a sustained drop in estrogen and progesterone; it typically occurs between ages 45 and 55 (average age 51 in Spain); it is preceded by perimenopause (years with irregular cycles and initial symptoms); it can involve symptoms that vary in intensity and duration, affecting the quality of life of millions of women, and for which there are pharmacological, nutritional, and lifestyle interventions with complementary profiles.
It is the most effective treatment for significant menopausal symptoms, with additional benefits for bone density and vaginal symptoms. After the findings of the WHI study in the early 2000s that raised concern, the modern assessment is more nuanced:
The decision is individualized with the gynecologist, considering symptoms, personal and family history, and preferences.
Soy isoflavones (40-80 mg/day): modest but significant reduction in hot flashes according to meta-analyses. Better response in women who produce equol.
Red clover isoflavones: similar support to soy.
Black cohosh: modest and heterogeneous support; traditional use in menopause.
Pueraria mirifica: a more potent phytoestrogen; caution because of its potency.
Andean maca (1,500-3,000 mg/day): improves menopausal well-being and libido without acting directly on estrogen receptors.
Sage: support for hot flashes.
Chasteberry: support for perimenopausal symptoms.
Royal jelly: modest support.
Evening primrose oil: modest support, better for breast pain than for hot flashes.
Magnesium, vitamin B6: modest support for symptoms.
Vitamin D and K2, calcium: for postmenopausal bone health.
Hydrolyzed collagen: modest support for skin and joints.
Cardiovascular risk increases significantly after menopause. Special attention to: - Blood pressure control. - Lipid profile. - Blood glucose. - Weight and body composition. - Bone densitometry as indicated.
Climacteric symptoms with a significant impact on quality of life, postmenopausal vaginal bleeding (which should always be evaluated), evaluation of hormone therapy, and assessment of postmenopausal cardiovascular and bone risk are indications for a gynecological/medical consultation.
Menopause is a physiological transition that benefits from comprehensive management: hormone replacement therapy in women with significant symptoms and no contraindications (an individualized decision), nutritional and supplement interventions (phytoestrogens, maca, sage) for those who prefer or need non-hormonal options, a solid lifestyle (exercise, Mediterranean diet, sleep, no tobacco, moderate alcohol), and attention to bone health (calcium, vitamin D, K2, strength exercise, densitometry) and cardiovascular health. It is a long life stage that deserves a comprehensive medical strategy, not passive resignation.
⏱ 3 min read
Menopause is a woman's physiological transition to the definitive cessation of ovarian function, with a sustained drop in estrogen and progesterone; it typically occurs between ages 45 and 55 (average age 51 in Spain); it is preceded by perimenopause (years with irregular cycles and initial symptoms); it can involve symptoms that vary in intensity and duration, affecting the quality of life of millions of women, and for which there are pharmacological, nutritional, and lifestyle interventions with complementary profiles.
It is the most effective treatment for significant menopausal symptoms, with additional benefits for bone density and vaginal symptoms. After the findings of the WHI study in the early 2000s that raised concern, the modern assessment is more nuanced:
The decision is individualized with the gynecologist, considering symptoms, personal and family history, and preferences.
Soy isoflavones (40-80 mg/day): modest but significant reduction in hot flashes according to meta-analyses. Better response in women who produce equol.
Red clover isoflavones: similar support to soy.
Black cohosh: modest and heterogeneous support; traditional use in menopause.
Pueraria mirifica: a more potent phytoestrogen; caution because of its potency.
Andean maca (1,500-3,000 mg/day): improves menopausal well-being and libido without acting directly on estrogen receptors.
Sage: support for hot flashes.
Chasteberry: support for perimenopausal symptoms.
Royal jelly: modest support.
Evening primrose oil: modest support, better for breast pain than for hot flashes.
Magnesium, vitamin B6: modest support for symptoms.
Vitamin D and K2, calcium: for postmenopausal bone health.
Hydrolyzed collagen: modest support for skin and joints.
Cardiovascular risk increases significantly after menopause. Special attention to: - Blood pressure control. - Lipid profile. - Blood glucose. - Weight and body composition. - Bone densitometry as indicated.
Climacteric symptoms with a significant impact on quality of life, postmenopausal vaginal bleeding (which should always be evaluated), evaluation of hormone therapy, and assessment of postmenopausal cardiovascular and bone risk are indications for a gynecological/medical consultation.
Menopause is a physiological transition that benefits from comprehensive management: hormone replacement therapy in women with significant symptoms and no contraindications (an individualized decision), nutritional and supplement interventions (phytoestrogens, maca, sage) for those who prefer or need non-hormonal options, a solid lifestyle (exercise, Mediterranean diet, sleep, no tobacco, moderate alcohol), and attention to bone health (calcium, vitamin D, K2, strength exercise, densitometry) and cardiovascular health. It is a long life stage that deserves a comprehensive medical strategy, not passive resignation.